CYR61 overexpression associated with the development and poor prognosis of ovarian carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

CYR61 overexpression associated with the development and poor prognosis of ovarian carcinoma

Published:2014-07-22 Issue:8 Volume:31 Page:
ISSN:1357-0560
Container-title:Medical Oncology
language:en
Short-container-title:Med Oncol

Author:

Shen Huimin,Cai Muyan,Zhao Shanshan,Wang Huan,Li Mengxiong,Yao Shuzhong,Jiang Nan

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Hematology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s12032-014-0117-2.pdf

Reference40 articles.

1. Fujita M, Enomoto T, Murata Y. Genetic alterations in ovarian carcinoma: with specific reference to histological subtypes. Mol Cell Endocrinol. 2003;202:97–9.

2. Barnett GL, Friedrich CA. Recent developments in ovarian cancer genetics. Curr Opin Obstet Gynecol. 2004;16:79–85.

3. Cannistra SA. Cancer of the ovary. N Engl J Med. 2004;351:2519–29.

4. Kurman RJ, Shih Ie M. The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory. Am J Surg Pathol. 2010;34:433–43.

5. Gomez-Raposo C, Mendiola M, Barriuso J, Hardisson D, Redondo A. Molecular characterization of ovarian cancer by gene-expression profiling. Gynecol Oncol. 2010;118:88–92.

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Single-Cell Dissection of the Multiomic Landscape of High-Grade Serous Ovarian Cancer;Cancer Research;2022-08-16

2. The Anti-Tumor Efficacy of Verbascoside on Ovarian Cancer via Facilitating CCN1-AKT/NF-κB Pathway-Mediated M1 Macrophage Polarization;Frontiers in Oncology;2022-06-17

3. Malignant Ascites in Ovarian Cancer: Cellular, Acellular, and Biophysical Determinants of Molecular Characteristics and Therapy Response;Cancers;2021-08-26

4. Serum CYR61 as a potential biomarker for the diagnosis of esophagogastric junction tumor;Bioscience Reports;2021-06

5. Identification of Potential Bisphenol A (BPA) Exposure Biomarkers in Ovarian Cancer;Journal of Clinical Medicine;2021-05-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3